Suchergebnisse - "Bührer, Christian"

PubPharm (7)

1

Correction to : Comparative Efficacy, Durability and Safety of Faricimab in the Treatment of Diabetic Macular Edema: A Systematic Literature Review and Network Meta-Analysis

enthalten in: Advances in therapy | 2024

von Watkins, C. | Paulo, T. | Bührer, C. | +2

ErratumFor: Adv Ther. 2023 Dec;40(12):5204-5221. - PMID 37751021

2

An eye on equity : faricimab-driven health equity improvements in diabetic macular oedema using a distributional cost-effectiveness analysis from a UK societal perspective

enthalten in: Eye (London, England) | 2024

von Meunier, A. | Opeifa, O. | Longworth, L. | +5

3

Correction to: Comparative Efficacy, Durability and Safety of Faricimab in the Treatment of Diabetic Macular Edema: A Systematic Literature Review and Network Meta-Analysis

enthalten in: Advances in therapy | 2024

von Watkins, C. | Paulo, T. | Bührer, C. | +2

4

Cost-Effectiveness of Faricimab in the Treatment of Diabetic Macular Oedema (DMO) : A UK Analysis

enthalten in: PharmacoEconomics - open | 2024

von Bührer, C. | Paling, T. | Gale, R. | +2

5

Comparative Efficacy, Durability and Safety of Faricimab in the Treatment of Diabetic Macular Edema : A Systematic Literature Review and Network Meta-Analysis

enthalten in: Advances in therapy | 2023

von Watkins, C. | Paulo, T. | Bührer, C. | +2

ErratumIn: Adv Ther. 2024 May;41(5):2084-2085. - PMID 38480662

6

Comparative Efficacy, Durability and Safety of Faricimab in the Treatment of Diabetic Macular Edema: A Systematic Literature Review and Network Meta-Analysis

enthalten in: Advances in therapy | 2023

von Watkins, C. | Paulo, T. | Bührer, C. | +2

7

Adverse selection in the German Health Insurance System - the case of civil servants

enthalten in: Health policy (Amsterdam, Netherlands) | 2020

von Bührer, C. | Fetzer, S. | Hagist, C.

1
[1]